NO20011656D0 - Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser - Google Patents
Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelserInfo
- Publication number
- NO20011656D0 NO20011656D0 NO20011656A NO20011656A NO20011656D0 NO 20011656 D0 NO20011656 D0 NO 20011656D0 NO 20011656 A NO20011656 A NO 20011656A NO 20011656 A NO20011656 A NO 20011656A NO 20011656 D0 NO20011656 D0 NO 20011656D0
- Authority
- NO
- Norway
- Prior art keywords
- drug delivery
- delivery systems
- animal applications
- mucosal
- mucosa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10295698P | 1998-10-02 | 1998-10-02 | |
| PCT/US1999/022967 WO2000019987A1 (en) | 1998-10-02 | 1999-10-01 | Mucosal originated drug delivery systems and animal applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011656L NO20011656L (no) | 2001-04-02 |
| NO20011656D0 true NO20011656D0 (no) | 2001-04-02 |
Family
ID=22292601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011656A NO20011656D0 (no) | 1998-10-02 | 2001-04-02 | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1117390B1 (no) |
| JP (1) | JP2002526403A (no) |
| KR (1) | KR20010075528A (no) |
| CN (1) | CN1321086A (no) |
| AT (1) | ATE273698T1 (no) |
| AU (1) | AU768040B2 (no) |
| BR (1) | BR9915020A (no) |
| CA (1) | CA2345808A1 (no) |
| CZ (1) | CZ20011188A3 (no) |
| DE (1) | DE69919554T2 (no) |
| ES (1) | ES2228125T3 (no) |
| HU (1) | HUP0103543A2 (no) |
| IL (1) | IL142168A0 (no) |
| MX (1) | MXPA01003310A (no) |
| NO (1) | NO20011656D0 (no) |
| NZ (1) | NZ510771A (no) |
| PL (1) | PL347061A1 (no) |
| PT (1) | PT1117390E (no) |
| WO (1) | WO2000019987A1 (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331539B1 (en) | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| DE10107659B4 (de) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
| AU2004278014B2 (en) | 2003-10-03 | 2011-04-28 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| AR046781A1 (es) | 2003-11-25 | 2005-12-21 | 3M Innovative Properties Co | Derivados de imidazoquinolinas. composiciones farmaceuticas. |
| FI20041425A0 (fi) | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
| JP2008530022A (ja) | 2005-02-04 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 免疫反応調節物質を含む水性ゲル処方物 |
| JP2006335640A (ja) * | 2005-05-06 | 2006-12-14 | Daicho Kikaku:Kk | 動物用薬剤 |
| KR101464003B1 (ko) * | 2005-07-29 | 2014-11-20 | 산텐 세이야꾸 가부시키가이샤 | 고형 조성물을 이용한 후안부 조직으로의 비침습성 약물전달 시스템 |
| WO2007103511A1 (en) * | 2006-03-07 | 2007-09-13 | Oramelts International, Inc. | Multi-layer medical patch with impermeable center |
| MX2009000745A (es) * | 2006-07-21 | 2009-04-16 | Biodelivery Sciences Int Inc | Dispositivos de suministro transmucosa con admision mejorada. |
| DE202008017304U1 (de) | 2008-02-29 | 2009-08-27 | Acino Ag | Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren |
| PE20120713A1 (es) * | 2009-05-15 | 2012-07-08 | Recro Pharma Inc | Composiciones sublinguales de dexmedetomidina y metodos para su uso |
| RU2012105524A (ru) * | 2009-07-17 | 2013-08-27 | Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити | Надъязычные вакцины и аппликаторы |
| EP2570217B1 (de) | 2011-09-15 | 2014-11-05 | Klingelnberg AG | Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| CA2924188C (en) * | 2013-10-07 | 2018-12-18 | Teikoku Pharma Usa, Inc. | Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions |
| RU2018105761A (ru) | 2013-10-07 | 2019-02-26 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Устройства для трансдермальной доставки дексмедетомидина и способы их применения |
| KR101881791B1 (ko) * | 2013-10-07 | 2018-07-25 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정성 덱스메데토미딘 경피 조성물을 사용하여 금단 증후군을 치료하기 위한 방법 및 조성물 |
| US20150098997A1 (en) | 2013-10-07 | 2015-04-09 | Teikoku Pharma Usa, Inc. | Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions |
| KR101891185B1 (ko) | 2013-10-07 | 2018-08-24 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB981372A (en) * | 1960-05-04 | 1965-01-27 | Pfizer Ltd | Pharmaceutical formulations for oral administration to animals |
| GB1455251A (en) * | 1972-08-25 | 1976-11-10 | Evode Ltd | Method of sealing gaps and compositions therefor heat |
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5346701A (en) * | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
| FR2712807B1 (fr) * | 1993-11-24 | 1996-02-23 | Vetoquinol Sa | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . |
| US5688520A (en) * | 1995-03-29 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Transmucosal delivery of melatonin for prevention of migraine |
-
1999
- 1999-10-01 PT PT99954718T patent/PT1117390E/pt unknown
- 1999-10-01 CN CN99811638A patent/CN1321086A/zh active Pending
- 1999-10-01 ES ES99954718T patent/ES2228125T3/es not_active Expired - Lifetime
- 1999-10-01 IL IL14216899A patent/IL142168A0/xx unknown
- 1999-10-01 KR KR1020017004162A patent/KR20010075528A/ko not_active Application Discontinuation
- 1999-10-01 WO PCT/US1999/022967 patent/WO2000019987A1/en active IP Right Grant
- 1999-10-01 EP EP99954718A patent/EP1117390B1/en not_active Expired - Lifetime
- 1999-10-01 CZ CZ20011188A patent/CZ20011188A3/cs unknown
- 1999-10-01 CA CA002345808A patent/CA2345808A1/en not_active Abandoned
- 1999-10-01 PL PL99347061A patent/PL347061A1/xx unknown
- 1999-10-01 MX MXPA01003310A patent/MXPA01003310A/es unknown
- 1999-10-01 HU HU0103543A patent/HUP0103543A2/hu unknown
- 1999-10-01 BR BR9915020-4A patent/BR9915020A/pt not_active Application Discontinuation
- 1999-10-01 AU AU11001/00A patent/AU768040B2/en not_active Ceased
- 1999-10-01 JP JP2000573348A patent/JP2002526403A/ja active Pending
- 1999-10-01 NZ NZ510771A patent/NZ510771A/en unknown
- 1999-10-01 AT AT99954718T patent/ATE273698T1/de not_active IP Right Cessation
- 1999-10-01 DE DE69919554T patent/DE69919554T2/de not_active Expired - Fee Related
-
2001
- 2001-04-02 NO NO20011656A patent/NO20011656D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69919554T2 (de) | 2005-09-01 |
| BR9915020A (pt) | 2001-08-14 |
| ATE273698T1 (de) | 2004-09-15 |
| ES2228125T3 (es) | 2005-04-01 |
| HUP0103543A2 (hu) | 2002-01-28 |
| CN1321086A (zh) | 2001-11-07 |
| IL142168A0 (en) | 2002-03-10 |
| MXPA01003310A (es) | 2003-05-15 |
| NO20011656L (no) | 2001-04-02 |
| WO2000019987A1 (en) | 2000-04-13 |
| JP2002526403A (ja) | 2002-08-20 |
| PT1117390E (pt) | 2005-01-31 |
| CA2345808A1 (en) | 2000-04-13 |
| CZ20011188A3 (cs) | 2001-08-15 |
| DE69919554D1 (de) | 2004-09-23 |
| AU768040B2 (en) | 2003-11-27 |
| EP1117390A1 (en) | 2001-07-25 |
| AU1100100A (en) | 2000-04-26 |
| PL347061A1 (en) | 2002-03-11 |
| EP1117390B1 (en) | 2004-08-18 |
| NZ510771A (en) | 2003-08-29 |
| KR20010075528A (ko) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20011656L (no) | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser | |
| EE9900481A (et) | Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks | |
| DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
| BRPI0411924A (pt) | métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos | |
| DE60041761D1 (de) | Tribonektine | |
| ATE531419T1 (de) | Vorrichtung zur verabreichung von therapeutischen mitteln | |
| NO974321D0 (no) | Nodulisporsyrederivater | |
| CY1109221T1 (el) | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
| DK1401422T3 (da) | Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
| DK1242012T3 (da) | Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde | |
| ATE337712T1 (de) | Zusammensetzung zur intestinalen verabreichung | |
| ATE249835T1 (de) | Immunoregulator | |
| IS5956A (is) | Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| CA2285477A1 (en) | Formulations and methods to treat and prevent equine protozoal myeloencephalitis | |
| ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| ATE234841T1 (de) | Nodulisporinsäurederivate | |
| DE60033397D1 (de) | Methode zur steigerung der produktionsleistung in tieren | |
| DE60035504D1 (de) | Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung | |
| UA31156A (uk) | Спосіб лікування пневмоентеритів телят | |
| WO2003028537A3 (en) | Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer | |
| UA38006A (uk) | Хондропротективний препарат | |
| WO2003007800A8 (en) | Methods for diagnosing and treating diseases and conditions of the digestive system and cancer | |
| UA36485A (uk) | Спосіб лікування генералізованого пародонтиту | |
| UA32146A (uk) | Спосіб оцінки ефективності лікування пародонтита |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |